glp-1 tired Fatigue Is Real: How I Finally Got My Energy Back GLP-1 Fatigue Explained: Why You're

10 In the DAPA-HF trial, among 4,700 patients with a significantly reduced mean LVEF (31% 6.7), most classified as New York Heart Association (NYHA) class II, dapagliflozin provided a 26% RR reduction in the primary composite outcome (CV death, HF hospitalisation and urgent visits for worsening HF), regardless of the presence or absence of type 2 diabetes (T2D), with a NNT of 21

Why Most GLP-1 Supplements Fail

Harrington MD, Michael Honigberg, Amy Sarma & Nandita Scott #WeHeartOurTeam Assistant Professor @ Harvard Medical School | Womens Heart Health Honored to lead this work addressing cardiometabolic health in pregnancy and the need for a more proactive approach to cardiovascular prevention and care in pregnant patients

Coetzee and me, develop personalized nutritional protocols

doi: 10.1097/FJC.0b013e3182949673